<DOC>
	<DOCNO>NCT03017586</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) globus pallidus internus ( GPi ) primary dystonia .</brief_summary>
	<brief_title>Efficacy Safety DBS Patients With Primary Dystonia</brief_title>
	<detailed_description>Dystonia uncommon brain disorder abnormal muscle tone produce twisting , writhe movement abnormal posture . It associate abnormal electrical activity two group nerve cell brain call globus pallidus internus ( GPi ) subthalamic nucleus ( STN ) . GPi DBS appear effective medication-refractory focal segmental dystonia affect cranial cervical region open-label series , recently GPi stimulation associate subtle motor disturbance previously non-dystonic body region ( i.e. , arm legs ) population patient . DBS STN also report effective treating generalize cervical dystonia small open label trial . STN DBS cranial cervical region may provide similar efficacy treatment dystonia GPi DBS , without unwanted stimulation-induced motor effect . Objectives study evaluate safety efficacy STN-DBS GPi-DBS dystonia ; Participants evaluate pre- postoperatively standard dystonia rating scale include Burke-Fahn-Marsden Dystonia rating scale ( BFMDRS ) , Changes cognitive function assess neuropsychological testing . Stimulation parameter document , patient questionnaire administer postoperatively determine patient experience stimulation-induced motor adverse effect . Patient weight record study visit . This pilot study provide preliminary open label efficacy outcomes STN DBS treatment primary dystonia help determine target compare GPi DBS large double-blind trial .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>1 . Refractory primary ( systemic , segmental ) dystonia diagnose movement disorder neurologist 2 . Severe functional impairment despite optimal medical management , include fail botulinum toxin therapy 3 . Ability follow postoperative study visit 4 . Patients relatives reasonable surgery expectation 5 . Volunteer participate clinical trial , sign consent form 6 . Age 660 year 1 . Pregnancy plan pregnancy 2 . Good treatment Noninvasive therapy 3 . Dopamine reactive dystonia ，Genetic degeneration ，Paroxysmal dystonia ，Secondary dystonia， Psychogenic dystonia 4 . Brain MRI show extensive brain atrophy small vessel ischemic disease 5 . Cognitive impairment ( MMSE &lt; 24 ) 6 . Severe depression serious mental illness 7 . History traumatic brain injury , tumor , severe cerebrovascular disease 8 . Severe brain atrophy ( diagnosed CT MRI ) 9 . Hyperthermia therapy implant part 10 . Abnormal blood inspection , blood clotting disorder , liver kidney dysfunction , clinical judgment tolerate surgery 11 . High blood pressure , serious heart disease , respiratory disease 12 . Diabetes 13 . Longterm treatment immunosuppressive hormone 14 . Implant pacemaker , defibrillator , cochlear nerve stimulators 15 . Other disease need frequent MRI examination 16 . Participated clinical trial within 3 month 17 . Reluctant unable implant surgery 18 . Reluctant unable cooperate followup 19 . Other exclusion Criteria researcher</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>